TRG Natural Pharmaceuticals was placed into liquidation in December, much to the surprise of its minor shareholders.
Fishy situation probed by liquidator.
Fletcher wants to use a controversial scheme-of-arrangement mechanism.
A director also left last month.
The good news keeps flowing.
But the Opposition gripes too many questions still unanswered and questions overall cost.
Fund manager Chris Swasbrook has support for a special meeting to roll directors.
UPDATE: Fletcher's response.
Also, US Fed paints a rosy picture of economy and clash in the South China Sea.
Ministers Woods and Nash hope the new scheme will boost New Zealand GDP.